1. Home
  2. HOUR vs LUNG Comparison

HOUR vs LUNG Comparison

Compare HOUR & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

HOLD

Current Price

$1.75

Market Cap

72.5M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.71

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOUR
LUNG
Founded
2015
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.5M
72.2M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
HOUR
LUNG
Price
$1.75
$1.71
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$6.81
AVG Volume (30 Days)
22.7K
325.0K
Earning Date
11-12-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$140,790,433.00
$91,664,000.00
Revenue This Year
N/A
$9.21
Revenue Next Year
N/A
$5.03
P/E Ratio
$73.69
N/A
Revenue Growth
N/A
15.59
52 Week Low
$1.10
$1.31
52 Week High
$6.84
$9.37

Technical Indicators

Market Signals
Indicator
HOUR
LUNG
Relative Strength Index (RSI) 44.74 36.16
Support Level $1.71 $1.68
Resistance Level $1.87 $1.92
Average True Range (ATR) 0.04 0.10
MACD 0.00 -0.02
Stochastic Oscillator 55.50 15.88

Price Performance

Historical Comparison
HOUR
LUNG

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: